Zybio Inc.

Call Directions Website Contact the business

Zybio Inc. Follow us to know more about our 8 product lines!

Zybio is dedicated to R&D, manufacture, sales and services of laboratory diagnostic devices, including Hematology, Urinalysis, Coagulation, Chemistry, CLIA, POCT, Molecular, Microbiology, etc. Zybio inc., established since 2008 and based in Chongqing China, is a high tech company specializing in the R&D, manufacture, sales, and service of IVD instruments and reagents.

🚀Your Future Starts Here! Zybio is Hiring Fresh Graduates! Zybio remains dedicated to the diagnostic sector with long-te...
07/10/2026

🚀Your Future Starts Here! Zybio is Hiring Fresh Graduates!

Zybio remains dedicated to the diagnostic sector with long-term commitment and sustained investment. We are currently looking for passionate, driven, and talented individuals to join our team across multiple fields.

📩How to apply:
Send your resume to [email protected] or scan the QR code in the image for online application!

Zybio was pleased to welcome international experts and partners to DiagHub 2026: Asia Microbiology & MALDI-TOF Conferenc...
24/09/2026

Zybio was pleased to welcome international experts and partners to DiagHub 2026: Asia Microbiology & MALDI-TOF Conference, held at Zybio Headquarters in Chongqing, China, from September 17-18, 2026.

Under the theme "Decoding Microbes, Defining Future", the event brought together experts and partners from around the world for academic exchange and discussion on the latest developments in MALDI-TOF mass spectrometry and clinical microbiology.

The program included a visit to Zybio Headquarters and New Technology Park, a visit to a local hospital to explore the clinical application of microbiology diagnostics, and engaging academic discussions throughout the conference.

We sincerely thank all the experts and partners who joined us and contributed to the success of DiagHub 2026. Together, we look forward to strengthening international collaboration and advancing the future of microbiology diagnostics.

What is it? Cocci, non-fermenting bacteria, Escherichia coli?This is a case reported from a hospital in China. A patient...
25/08/2026

What is it? Cocci, non-fermenting bacteria, Escherichia coli?
This is a case reported from a hospital in China. A patient suspected with urinary tract infection was prescribed with urine analysis. Figure 1 is the Gram staining of the specimen, indicating Gram-negative cocci.

After inoculation, the original plate (Fig 2) and the growth of separated colony at 24h (Fig 3) and 48h (Fig 4) all indicated atypical enteric bacilli, resembling non-fermenting bacteria.

Traditional biochemical identification has reached a stalemate—the direction has been wrong.

At this point, MALDI-TOF MS comes into play. It identifies bacteria directly from their protein fingerprints, regardless of morphology or culture characteristics, and quickly provides high-confidence results: Escherichia coli. (Fig 5)

The mass spectrometry results were in complete agreement with the subsequent oxidase test (Fig 6, negative) and MacConkey plate test (Fig 7, pink colonies, fermenting lactose), forming a complete chain of evidence.

Though there was doubt between the different microscopic, inoculation and mass spectrometry results, based on the patient's typical infection symptoms, urinary nitrite level (2+), and history of multiple anti-infective treatments, it was finally speculated as L-form bacteria.

L-form bacteria are variants with partial or complete loss of cell wall, and the common cause is β-lactam antibiotics (this patient had received multiple anti-infective treatments).
In hypertonic urine, Escherichia coli "abandons its cell wall" and transforms into cocci-like L-form in order to survive, thus changing its culture characteristics and deceiving microscopic examination and routine culture.

Verification: The lab technician inoculated the specimens into nutrient-rich liquid medium (blood culture bottles), passaged them, and cultured them under suitable conditions, monitoring them hourly. Ultimately, Escherichia coli recovered its typical rod-shaped morphology and colony characteristics, confirming the accuracy of the original mass spectrometry identification.

📌Key characteristics of L-type bacteria:
✅Hypertonic (must survive in a hypertonic environment)
✅Atavism (can be restored to its original state after the removal of inducing factors, and is divided into variable and stable types).
✅Weak antigenicity (easily evades the immune system, leading to chronic infection)
✅Clinical warning: If a patient has obvious symptoms but a negative routine culture, especially if they have used β-lactam antibiotics, be alert to L-type infection. Special isolation and culture are required, and medication should be adjusted accordingly.

From the EXS 2600 MALDI-TOF MS System and EXB 60/120 Blood Culture Systems to the EXS 800 Teaching TOF MS and EXQ 3600 T...
20/08/2026

From the EXS 2600 MALDI-TOF MS System and EXB 60/120 Blood Culture Systems to the EXS 800 Teaching TOF MS and EXQ 3600 Triple Quadrupole MS Systems—our technological portfolio has grown significantly.
And our evolution goes beyond hardware. We've moved from a standard PMF database to a powerful integration with genome-based predictive databases for MALDI-TOF MS, expanding our identification coverage to over 14,000 species.
This is the journey of Zybio advancing microbiological diagnostics and MS for precision that protects life, and you can always count on our steadfast dedication to accuracy at every step.

Service Upgrade! Zybio's remote service platform, Zybio-Link, has officially been upgraded to V2.0—taking our after-sale...
18/08/2026

Service Upgrade! Zybio's remote service platform, Zybio-Link, has officially been upgraded to V2.0—taking our after-sales support to the next level.

What does this mean for you? Access to an expansive self-service data platform, plus a closer, faster connection to our HQ support team, now powered by both advanced AI and our expert engineers.

Experience the new Zybio-Link V2.0 today—simply scan the QR code in the picture or visit our portal directly: https://cs.zybio.com

📢Another Milestone in Clinical Chemistry – from Zybio!We are proud to announce that our scientific abstract has been acc...
13/08/2026

📢Another Milestone in Clinical Chemistry – from Zybio!
We are proud to announce that our scientific abstract has been accepted for presentation at ADLM — a testament to our commitment to advancing diagnostic innovation. Our study introduces a novel oligomeric antibody-based immunoturbidimetric assay for HbA1c detection, addressing the key limitations of traditional methods while delivering performance comparable to the HPLC gold standard.

HPLC remains the gold standard for HbA1c testing, but it is slow and costly. Traditional immunoturbidimetric assays offer speed but compromise on stability and complexity. Our oligomeric antibody technology bridges this gap — delivering HPLC-comparable accuracy on an automated, high-speed platform that is practical, cost-effective, and ready for routine diagnostics.

In a study of 194 clinical samples, our kit demonstrated excellent consistency with the HPLC gold standard (Arkray HA-8180), with a correlation coefficient r = 0.9928— well above the required threshold of 0.975. While traditional immunoturbidimetric assays show low-end repeatability CV of 7%, our kit achieves a remarkable CV < 2.5% — delivering the reliability that clinicians and laboratories demand. After 30 days of in-use stability, our reagent showed a relative deviation of < 5% , compared to >7% deviation for traditional methods after just 15 days. That means less waste, fewer recalibrations, and greater confidence in every run.
Curious about more details? Follow us and get in touch with Zybio Team 🙌

We’ve been upgraded—small size, scalable modular, and CE-IVDR approved! EXB 60 Blood Culture System is not just a smalle...
10/08/2026

We’ve been upgraded—small size, scalable modular, and CE-IVDR approved! EXB 60 Blood Culture System is not just a smaller footprint, but a more scalable design flexible to your needs.
⚡Fast & Sensitive: Positive in 3 hours with 1 CFU/bottle detection limit for earlier intervention.
🧫Broad & Powerful: Covers 90%+ pathogens with multi-resin antibiotic neutralization and optimized culture media for enhanced recovery of fastidious microorganisms, including direct CSF culture.
📲Smart & Connected: 60-600+ bottle modular scalability, automatic barcode scanning, blood volume detection, real-time alerts, LIS integration, and centralized data management.
Curious about more details? Send us a DM to get in touch with Zybio Team🙌

📢New Data from Zybio at ADLM!Lipemic samples and cross-platform variability have long plagued lipid testing. Our new stu...
06/08/2026

📢New Data from Zybio at ADLM!
Lipemic samples and cross-platform variability have long plagued lipid testing. Our new study introduces a multi-dimensional lipid dissociation technology that tackles both—ensuring accuracy even in turbid samples, and consistent results across different analyzers.

We tested 6 core lipids (HDL-C, LDL-C, CHOL, TG, APOA1, APOB) across 5 systems (Three Zybio EXC series, the mainstream international clinical chemistry analyzer A, the mainstream international clinical chemistry analyzer B) vs. the mainstream international clinical chemistry analyzer C reference, using 660 samples (incl. 180 lipemic samples).
✅ Across 5 systems: r > 0.995 | concordance > 98%
✅ vs. mainstream international clinical chemistry analyzer C reference: r > 0.992 | concordance > 95%
✅ Lipemic samples: Zero clinically discrepant results.

Our technology effectively breaks down chylomicrons and eliminates matrix interference—delivering reliable results regardless of sample turbidity or instrument brand. Backed by Zybio’s international traceability framework, this ensures your lab gets true, standardised cardiovascular risk assessment, every time.
Curious about more details? Follow us and get in touch with Zybio Team 🙌

Address

Floor 1 To Floor 5, Building 30, No. 6 Of Taikang Road, Block C Of Jianqiao Industrial Park, Dadukou District
Chongqing
400082

Alerts

Be the first to know and let us send you an email when Zybio Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Zybio Inc.:

Shortcuts

Share